This COBRE pilot project was funded by the COBRE Center for Pediatric Research. It explored computational approaches to integrate RNA-seq and microarray expression profiles of unmatched samples to find expression signatures with clinical prognostic relevance to pediatric B-cell acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients